8-K: Nu Skin Enterprises Reports Q2 2026 Results: Revenue Down 17.1%

Nu Skin Enterprises announced a significant year-over-year revenue decrease of 17.1% for the second quarter of 2026, alongside a substantial net loss and a large impairment charge.

Summary

• Nu Skin Enterprises reported second quarter 2026 revenue of $320.1 million, a 17.1% decrease compared to the prior year quarter.
• The company reported a net loss of $249.8 million, or $(5.14) per share, for the quarter.
• Excluding non-cash impairment and tax charges, adjusted earnings per share (EPS) were $0.20, down from $0.43 in the prior year quarter.
• Total customers decreased by 14% to 660,037, and paid affiliates decreased by 8% to 120,291.
• A significant non-cash impairment charge of $78.9 million was recorded in the quarter.
• The company provided an outlook for Q3 2026 revenue between $310 million and $340 million, and full-year 2026 revenue between $1.28 billion and $1.35 billion.
• Adjusted full-year 2026 EPS is projected to be between $0.70 and $0.90.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a negative report due to significant revenue and customer declines, a substantial net loss, and a large impairment charge, despite management's strategic initiatives.

Positives

• Adjusted earnings per share of $0.20 for Q2 2026 were near the midpoint of guidance.
• The company continues to make progress on its long-term strategy with the rollout of Prysm iO and preparations for the India launch.
• Stock repurchases of $0.0 million were made, with $137.3 million remaining under the authorization.

Negatives

• Revenue for Q2 2026 decreased by 17.1% to $320.1 million compared to $386.1 million in the prior year quarter.
• A substantial net loss of $249.8 million was reported for Q2 2026.
• Diluted EPS was $(5.14) for Q2 2026, a significant drop from $0.43 in the prior year quarter.
• Total customers declined by 14% year-over-year to 660,037.
• Paid Affiliates decreased by 8% to 120,291, and Sales Leaders decreased by 9% to 26,998.
• A significant non-cash impairment charge of $78.9 million was recognized in the quarter.
• Gross margin slightly decreased to 68.2% from 68.8% in the prior year quarter.
• Operating margin was (18.5)%, or 6.1% excluding the impairment charge, down from 8.0% in the prior year quarter.

Risks

• Failure of current or planned initiatives or products to generate sustained interest among the sales force and customers.
• Direct selling laws and regulations in any of the company's markets may be modified, interpreted, or enforced in a manner that negatively impacts the business model, revenue, or sales force.
• Global economic conditions and events.
• Adverse results of tax audits or unfavorable changes to tax laws in various markets.
• Competitive pressures in the company's markets.
• Epidemics or other crises and related disruptions could negatively impact the business.
• Adverse publicity related to the company's business, products, industry, or legal actions.
• Political, legal, tax, and regulatory uncertainties, including trade policies, associated with operating in Mainland China and other international markets.

Future Outlook

For the third quarter of 2026, revenue is projected to be between $310 million and $340 million, with adjusted EPS between $0.10 and $0.20. For the full year 2026, revenue is expected to be between $1.28 billion and $1.35 billion, with adjusted EPS between $0.70 and $0.90.

Management Comments

• "We continue to make progress toward our long-term strategy with the continued rollout of Prysm iO and preparations for the formal launch of India, said Ryan Napierski, Nu Skin president and CEO. As these initiatives are taking hold, we are incorporating valuable learnings to strengthen our plans moving forward. At the same time, we are re-aligning our organizational resources to better position the business to drive sustainable, long-term value for our shareholders."
• "We delivered adjusted earnings per share near the midpoint of our guidance, reflecting our ongoing focus on profitability and disciplined execution," said Chelsea Lantz, interim chief financial officer. "Based on our first-half performance and outlook for the rest of the year, we are updating our annual guidance to revenue of $1.28 billion to $1.35 billion and adjusted earnings per share of $0.70 to $0.90. For the third quarter, we expect revenue between $310 million and $340 million, with adjusted earnings per share in the range of $0.10 to $0.20."

Industry Context

StockSavvy.ai notes that Nu Skin's results reflect broader challenges in the direct selling and beauty/wellness sectors, which are experiencing shifts in consumer behavior and increased competition. The significant decline in customers and revenue suggests difficulties in adapting to evolving market dynamics or executing strategic initiatives effectively.

Stakeholder Impact

• Shareholders: The significant revenue decline, net loss, and reduced EPS negatively impact shareholder value and may lead to a decrease in stock price.
• Employees: Re-alignment of organizational resources may lead to restructuring or changes in workforce.
• Sales Force (Affiliates): Declines in customers and paid affiliates directly affect the earning potential of the sales force.
• Suppliers: Reduced sales volume may lead to lower demand for products, potentially impacting suppliers.

Next Steps

• Continue rollout of Prysm iO.
• Prepare for the formal launch of operations in India.
• Re-align organizational resources to drive sustainable, long-term value.
• Host a conference call with the investment community on August 10, 2026, at 5 p.m. ET.

Key Dates

Recommendation

The filing indicates a severe downturn with significant revenue and customer declines, a substantial net loss, and a large impairment charge. Despite management's strategic initiatives, the current performance and outlook suggest ongoing challenges that are likely to negatively impact the stock price, warranting a sell recommendation.

Keywords

direct selling, beauty, wellness, multi-level marketing, affiliate marketing, consumer products, financial results, revenue